Gain Therapeutics (GANX)
(Delayed Data from NSDQ)
$1.43 USD
-0.07 (-4.35%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.43 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.23 | 0.00% |
Earnings Summary
For their last quarter, Gain Therapeutics (GANX) reported earnings of -$0.42 per share, missing the Zacks Consensus Estimate of -$0.31 per share. This reflects a negative earnings surprise of 35.48%. Look out for GANX's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.23 per share, reflecting a year-over-year increase of 37.84%.
Earnings History
Price & Consensus
Zacks News for GANX
Adherex Technologies Inc. (FENC) Lags Q1 Earnings Estimates
GANX: What are Zacks experts saying now?
Zacks Private Portfolio Services